UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 185

Sortiert nach

Are genetic and idiopathic forms of Parkinson's disease the same disease?

Journal of neurochemistry, 2020-03, Vol.152 (5), p.515-522

2020

Volltextzugriff (PDF)

Upper motor neuron signs in primary lateral sclerosis and hereditary spastic paraplegia

Muscle & nerve, 2024-07, Vol.70 (1), p.152-156

2024

Volltextzugriff (PDF)

The molecular appearance of native TRPM7 channel complexes identified by high-resolution proteomics

eLife, 2021-11, Vol.10

2021

Volltextzugriff (PDF)

Structural mechanisms of TRPM7 activation and inhibition

Nature communications, 2023-05, Vol.14 (1), p.2639-2639, Article 2639

2023

Volltextzugriff (PDF)

Do patients with late-stage Parkinson’s disease still respond to levodopa?

Parkinsonism & related disorders, 2016-05, Vol.26, p.10-16

2016

Volltextzugriff (PDF)

Tremor and Parkinsonism in Chromosomopathies — A Systematic Review

Movement disorders, 2021-09, Vol.36 (9), p.2017-2025

2021

Volltextzugriff (PDF)

A distinct neuromelanin magnetic resonance imaging pattern in parkinsonian multiple system atrophy

BMC neurology, 2020-11, Vol.20 (1), p.432-432, Article 432

2020

Volltextzugriff (PDF)

HSD10 disease in a female patient with juvenile onset parkinsonism

Movement disorders clinical practice (Hoboken, N.J.), 2024-04, Vol.11 (4), p.431-433

2024

Volltextzugriff (PDF)

Circulating Inflammatory miRNAs Associated with Parkinson's Disease Pathophysiology

Biomolecules (Basel, Switzerland), 2020-06, Vol.10 (6), p.945

2020

Volltextzugriff (PDF)

Survival, Mortality, Causes and Places of Death in a European Huntington's Disease Prospective Cohort

Movement disorders clinical practice (Hoboken, N.J.), 2017-09, Vol.4 (5), p.737-742

2017

Volltextzugriff (PDF)

Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease

Movement disorders, 2015-06, Vol.30 (7), p.953-959

2015

Volltextzugriff (PDF)

3D Kinematics Quantifies Gait Response to Levodopa earlier and to a more Comprehensive Extent than the MDS‐Unified Parkinson's Disease Rating Scale in Patients with Motor Complications

Movement disorders clinical practice (Hoboken, N.J.), 2024-07, Vol.11 (7), p.795-807

2024

Volltextzugriff (PDF)

Speech and Voice Response to a Levodopa Challenge in Late-Stage Parkinson's Disease

Frontiers in neurology, 2017-08, Vol.8, p.432-432

2017

Volltextzugriff (PDF)

Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease

Scientific reports, 2017-10, Vol.7 (1), p.13713-11, Article 13713

2017

Volltextzugriff (PDF)

Hydrophilic bile acids protect human blood-brain barrier endothelial cells from disruption by unconjugated bilirubin: an in vitro study

Frontiers in neuroscience, 2015-03, Vol.9, p.80-80

2015

Volltextzugriff (PDF)

Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease

Journal of Parkinson's disease, 2017, Vol.7 (3), p.491

2017

Volltextzugriff (PDF)

Acute response of non-motor symptoms to subthalamic deep brain stimulation in Parkinson's disease

Parkinsonism & related disorders, 2017-08, Vol.41, p.113-117

2017

Volltextzugriff (PDF)

Handicap as a Measure of Perceived‐Health Status in Parkinson's Disease

Movement disorders clinical practice (Hoboken, N.J.), 2023-08, Vol.10 (8), p.1172-1180

2023

Volltextzugriff (PDF)

Don’t Disregard Deep Brain Stimulation in Patients with Concomitant Gaucher and Parkinson Disease

NeuroRegulation, 2020, Vol.7 (2), p.95-97

2020

Volltextzugriff (PDF)

High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal

Movement disorders, 2007-06, Vol.22 (8), p.1194-1201

2007

Volltextzugriff (PDF)

Molecular Characterization of Portuguese Patients with Hereditary Cerebellar Ataxia

Cells (Basel, Switzerland), 2022-03, Vol.11 (6), p.981

2022

Volltextzugriff (PDF)

Patients and Health Professional's Perspective of Functional Mobility in Parkinson's Disease

Frontiers in neurology, 2020-10, Vol.11, p.575811-575811

2020

Volltextzugriff (PDF)

Neuromelanin Magnetic Resonance Imaging of the Substantia Nigra in Huntington's Disease

Journal of Huntington's disease, 2020-01, Vol.9 (2), p.143

2020

Volltextzugriff (PDF)

Musician's Dystonia as the Initial Presentation of Parkinson's Disease

Movement disorders clinical practice (Hoboken, N.J.), 2016-11, Vol.3 (6), p.624-625

2016

Volltextzugriff (PDF)

miR-335 Targets LRRK2 and Mitigates Inflammation in Parkinson’s Disease

Frontiers in cell and developmental biology, 2021-06, Vol.9, p.661461-661461

2021

Volltextzugriff (PDF)

1 – 25 von 185

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(143)
Mit Volltextzugriff
(152)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Are genetic and idiopathic forms of Parkinson's disease the same disease?

Upper motor neuron signs in primary lateral sclerosis and hereditary spastic paraplegia

The molecular appearance of native TRPM7 channel complexes identified by high-resolution proteomics

Structural mechanisms of TRPM7 activation and inhibition

Do patients with late-stage Parkinson’s disease still respond to levodopa?

Tremor and Parkinsonism in Chromosomopathies — A Systematic Review

A distinct neuromelanin magnetic resonance imaging pattern in parkinsonian multiple system atrophy

HSD10 disease in a female patient with juvenile onset parkinsonism

Circulating Inflammatory miRNAs Associated with Parkinson's Disease Pathophysiology

Survival, Mortality, Causes and Places of Death in a European Huntington's Disease Prospective Cohort

Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease

3D Kinematics Quantifies Gait Response to Levodopa earlier and to a more Comprehensive Extent than the MDS‐Unified Parkinson's Disease Rating Scale in Patients with Motor Complications

Speech and Voice Response to a Levodopa Challenge in Late-Stage Parkinson's Disease

Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease

Hydrophilic bile acids protect human blood-brain barrier endothelial cells from disruption by unconjugated bilirubin: an in vitro study

Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease

Acute response of non-motor symptoms to subthalamic deep brain stimulation in Parkinson's disease

Handicap as a Measure of Perceived‐Health Status in Parkinson's Disease

Don’t Disregard Deep Brain Stimulation in Patients with Concomitant Gaucher and Parkinson Disease

High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal

Molecular Characterization of Portuguese Patients with Hereditary Cerebellar Ataxia

Patients and Health Professional's Perspective of Functional Mobility in Parkinson's Disease

Neuromelanin Magnetic Resonance Imaging of the Substantia Nigra in Huntington's Disease

Musician's Dystonia as the Initial Presentation of Parkinson's Disease

miR-335 Targets LRRK2 and Mitigates Inflammation in Parkinson’s Disease

Suchergebnisse filtern